Clinical data reveal inconsistent correlations between IL-17A levels and disease severity: some studies associate elevated serum IL-17A with severe pneumonia and adverse outcomes (53), whereas Yang et al. This evidence concerns the gene IL17A and susceptibility to pneumonia measurement.